Population trends in aspirin use for cardiovascular disease prevention 1980-2009

The minnesota heart survey

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background-Daily low-dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher-risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. Methods and Results-Surveys of randomly selected adults aged 25 to 74 years were collected at 5-year intervals. Self-reports of regular aspirin use for CVD prevention and history of CVD were obtained. Six cross-sectional surveys included 12 281 men and 14 258 women. Age-adjusted aspirin use for primary prevention increased during this period from 1% to 21% among men and 1% to 12% among women. Aspirin use was highest in those aged 65 to 74 years. For secondary prevention, age-adjusted aspirin use increased from 19% to 74% among men and 11% to 64% among women. While data are based on self-report, a substudy using a biochemical indicator of aspirin use (serum thromboxane B2) supports the validity of self-report. Conclusions-Aspirin for CVD prevention is commonly used by a large and growing portion of the general population. It is not known if this is based on professional advice or self-prescribed use. It is also likely that many who would benefit do not use aspirin and others use aspirin inappropriately.

Original languageEnglish (US)
Article numbere002320
JournalJournal of the American Heart Association
Volume4
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Aspirin
Cardiovascular Diseases
Population
Self Report
Primary Prevention
Surveys and Questionnaires
Thromboxane B2
Urban Population
Secondary Prevention
Cross-Sectional Studies
Stroke
Myocardial Infarction
Serum

Keywords

  • Aspirin
  • Epidemiology
  • Prevention

Cite this

@article{d8ecc9306fa14a2ca62f0384e3e2bcbb,
title = "Population trends in aspirin use for cardiovascular disease prevention 1980-2009: The minnesota heart survey",
abstract = "Background-Daily low-dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher-risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. Methods and Results-Surveys of randomly selected adults aged 25 to 74 years were collected at 5-year intervals. Self-reports of regular aspirin use for CVD prevention and history of CVD were obtained. Six cross-sectional surveys included 12 281 men and 14 258 women. Age-adjusted aspirin use for primary prevention increased during this period from 1{\%} to 21{\%} among men and 1{\%} to 12{\%} among women. Aspirin use was highest in those aged 65 to 74 years. For secondary prevention, age-adjusted aspirin use increased from 19{\%} to 74{\%} among men and 11{\%} to 64{\%} among women. While data are based on self-report, a substudy using a biochemical indicator of aspirin use (serum thromboxane B2) supports the validity of self-report. Conclusions-Aspirin for CVD prevention is commonly used by a large and growing portion of the general population. It is not known if this is based on professional advice or self-prescribed use. It is also likely that many who would benefit do not use aspirin and others use aspirin inappropriately.",
keywords = "Aspirin, Epidemiology, Prevention",
author = "Luepker, {Russell V} and Steffen, {Lyn M} and Sue Duval and Zantek, {Nicole D} and Xia Zhou and Hirsch, {Alan T}",
year = "2015",
month = "12",
day = "1",
doi = "10.1161/JAHA.115.002320",
language = "English (US)",
volume = "4",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Population trends in aspirin use for cardiovascular disease prevention 1980-2009

T2 - The minnesota heart survey

AU - Luepker, Russell V

AU - Steffen, Lyn M

AU - Duval, Sue

AU - Zantek, Nicole D

AU - Zhou, Xia

AU - Hirsch, Alan T

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background-Daily low-dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher-risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. Methods and Results-Surveys of randomly selected adults aged 25 to 74 years were collected at 5-year intervals. Self-reports of regular aspirin use for CVD prevention and history of CVD were obtained. Six cross-sectional surveys included 12 281 men and 14 258 women. Age-adjusted aspirin use for primary prevention increased during this period from 1% to 21% among men and 1% to 12% among women. Aspirin use was highest in those aged 65 to 74 years. For secondary prevention, age-adjusted aspirin use increased from 19% to 74% among men and 11% to 64% among women. While data are based on self-report, a substudy using a biochemical indicator of aspirin use (serum thromboxane B2) supports the validity of self-report. Conclusions-Aspirin for CVD prevention is commonly used by a large and growing portion of the general population. It is not known if this is based on professional advice or self-prescribed use. It is also likely that many who would benefit do not use aspirin and others use aspirin inappropriately.

AB - Background-Daily low-dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher-risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. Methods and Results-Surveys of randomly selected adults aged 25 to 74 years were collected at 5-year intervals. Self-reports of regular aspirin use for CVD prevention and history of CVD were obtained. Six cross-sectional surveys included 12 281 men and 14 258 women. Age-adjusted aspirin use for primary prevention increased during this period from 1% to 21% among men and 1% to 12% among women. Aspirin use was highest in those aged 65 to 74 years. For secondary prevention, age-adjusted aspirin use increased from 19% to 74% among men and 11% to 64% among women. While data are based on self-report, a substudy using a biochemical indicator of aspirin use (serum thromboxane B2) supports the validity of self-report. Conclusions-Aspirin for CVD prevention is commonly used by a large and growing portion of the general population. It is not known if this is based on professional advice or self-prescribed use. It is also likely that many who would benefit do not use aspirin and others use aspirin inappropriately.

KW - Aspirin

KW - Epidemiology

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=84991521223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991521223&partnerID=8YFLogxK

U2 - 10.1161/JAHA.115.002320

DO - 10.1161/JAHA.115.002320

M3 - Article

VL - 4

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 12

M1 - e002320

ER -